STOCK TITAN
  1. Home
  2. Sec-filings
  3. TXG
  4. [Form 4] 10x Genomics, Inc. Insider Trading Activity

10x Genomics (TXG) director receives 8,829 RSU grant, lifts holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kosaraju Sridhar reported acquisition or exercise transactions in this Form 4 filing.

10x Genomics director Sridhar Kosaraju reported a stock-based compensation award. He received a grant of 8,829 shares of Class A Common Stock as restricted stock units (RSUs) at no cash cost. After this grant, he holds 65,278 shares directly.

The RSUs vest in four equal installments on each quarterly anniversary starting on May 21, 2026, as long as he continues as a service provider through each vesting date. The filing also shows 3,000 Class A shares held indirectly through the Kosaraju Family Trust, where he serves as trustee.

Positive

  • None.

Negative

  • None.
Insider Kosaraju Sridhar
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 8,829 $0.00 --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 65,278 shares (Direct, null); Class A Common Stock — 3,000 shares (Indirect, See footnote)
Footnotes (1)
  1. Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date. These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.
RSU grant size 8,829 RSUs Grant of Class A Common Stock RSUs to director
Grant price $0.0000 per share Reported price per share for RSU grant
Direct holdings after grant 65,278 shares Class A Common Stock held directly after transaction
Indirect holdings 3,000 shares Class A Common Stock held via Kosaraju Family Trust
Vesting start date May 21, 2026 Quarterly vesting anniversaries measured from this date
Vesting structure 1/4 each quarter RSUs vest in four equal quarterly installments
restricted stock units ("RSUs") financial
"Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Class A Common Stock financial
"Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
quarterly anniversary financial
"1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026"
A quarterly anniversary marks the date that occurs every three months after a specific event, such as an investment or a business milestone. It is similar to a birthday that repeats four times a year, helping investors track the timing of important updates or changes. Recognizing these anniversaries allows investors to stay informed about progress and make timely decisions.
service provider financial
"subject to the Reporting Person continuing as a service provider through each such date"
Family Trust financial
"These shares are held by the Kosaraju Family Trust dated June 21, 2014"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kosaraju Sridhar
(Last)(First)(Middle)
C/O 10X GENOMICS, INC.
6230 STONERIDGE MALL ROAD
(Street)
PLEASANTON CALIFORNIA 94588
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
10x Genomics, Inc. [ TXG ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/04/2026A8,829(1)A$065,278D
Class A Common Stock3,000ISee footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date.
2. These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Randy Wu, as Attorney-in-Fact for Sridhar Kosaraju06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did 10x Genomics (TXG) director Sridhar Kosaraju report in this Form 4?

He reported receiving 8,829 restricted stock units of Class A Common Stock as a stock-based compensation grant. These RSUs convert into shares over time, increasing his direct holdings to 65,278 shares plus 3,000 shares held indirectly through a family trust.

How many 10x Genomics (TXG) shares did Sridhar Kosaraju acquire in this transaction?

He acquired 8,829 restricted stock units, each representing one share of Class A Common Stock upon vesting. The grant was recorded at a price of $0.0000 per share, reflecting compensation rather than a cash purchase on the open market.

What is the vesting schedule for Sridhar Kosaraju’s 10x Genomics (TXG) RSUs?

The 8,829 RSUs vest in four equal parts, with one-quarter vesting on each quarterly anniversary starting from May 21, 2026. Vesting is contingent on him continuing as a service provider to 10x Genomics on each applicable vesting date.

How many 10x Genomics (TXG) shares does Sridhar Kosaraju hold after this Form 4?

After the reported grant, he holds 65,278 Class A Common Stock shares directly. In addition, 3,000 shares are held indirectly by the Kosaraju Family Trust, where he is the trustee, as disclosed in the Form 4 footnotes.

Are Sridhar Kosaraju’s new 10x Genomics (TXG) RSUs an open-market purchase?

No, the filing shows a grant coded as an award acquisition with a price of $0.0000 per share. This indicates stock-based compensation rather than an open-market purchase, which would typically involve a transaction price and a purchase code.